{"filing":{"accession_number":"0001730463-26-000072","cik":"0001730463","ticker":"AUTL","company_name":"Autolus Therapeutics plc","form":"8-K","filing_date":"2026-06-29","report_date":null,"primary_document":"autl-20260629.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1730463/000173046326000072/autl-20260629.htm"},"events":[{"id":14597,"run_id":13006,"accession_number":"0001730463-26-000072","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from the 2026 Annual General Meeting held on June 29, 2026. The filing reports the outcomes of six ordinary resolutions, including adoption of annual accounts, approval of directors' remuneration, auditor appointment (Ernst \u0026 Young LLP), and re-election of three directors (M Bonney, E Leiderman, and RW Azelby), with vote tallies for each resolution. This is a quintessential Item 5.07 disclosure and is material to investors as it reflects shareholder governance decisions and approval of key corporate matters.","company_name":"Autolus Therapeutics plc","ticker":"AUTL","filing_date":"2026-06-29","form":"8-K","submitted_at":null,"items":[{"id":12077,"accession_number":"0001730463-26-000072","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the 2026 Annual General Meeting held on June 29, 2026. The filing reports the outcomes of six ordinary resolutions, including adoption of annual accounts, approval of directors' remuneration, auditor appointment (Ernst \u0026 Young LLP), and re-election of three directors (M Bonney, E Leiderman, and RW Azelby), with vote tallies for each resolution. This is a quintessential Item 5.07 disclosure and is material to investors as it reflects shareholder governance decisions and approval of key corporate matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T20:05:39.482870+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":12077,"accession_number":"0001730463-26-000072","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the 2026 Annual General Meeting held on June 29, 2026. The filing reports the outcomes of six ordinary resolutions, including adoption of annual accounts, approval of directors' remuneration, auditor appointment (Ernst \u0026 Young LLP), and re-election of three directors (M Bonney, E Leiderman, and RW Azelby), with vote tallies for each resolution. This is a quintessential Item 5.07 disclosure and is material to investors as it reflects shareholder governance decisions and approval of key corporate matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T20:05:39.482870+00:00","company_name":"Autolus Therapeutics plc","ticker":"AUTL","filing_date":"2026-06-29"}]}